Literature DB >> 28859227

Transmembrane BAX Inhibitor motif-containing 1, a novel anti-inflammatory approach for nonalcoholic steatohepatitis treatment.

Alexander Wree1,2, Maria Eugenia Inzaugarat1, Ariel E Feldstein2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 28859227      PMCID: PMC5770148          DOI: 10.1002/hep.29495

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  8 in total

1.  Differential regulation of inflammation and apoptosis in Fas-resistant hepatocyte-specific Bid-deficient mice.

Authors:  Milos Lazic; Akiko Eguchi; Michael P Berk; Davide Povero; Bettina Papouchado; Anny Mulya; Casey D Johnson; Ariel E Feldstein
Journal:  J Hepatol       Date:  2014-03-27       Impact factor: 25.083

Review 2.  Intracellular protein degradation: from a vague idea thru the lysosome and the ubiquitin-proteasome system and onto human diseases and drug targeting.

Authors:  A Ciechanover
Journal:  Cell Death Differ       Date:  2005-09       Impact factor: 15.828

3.  Targeting CASP8 and FADD-like apoptosis regulator ameliorates nonalcoholic steatohepatitis in mice and nonhuman primates.

Authors:  Pi-Xiao Wang; Yan-Xiao Ji; Xiao-Jing Zhang; Ling-Ping Zhao; Zhen-Zhen Yan; Peng Zhang; Li-Jun Shen; Xia Yang; Jing Fang; Song Tian; Xue-Yong Zhu; Jun Gong; Xin Zhang; Qiao-Fang Wei; Yong Wang; Jing Li; Lu Wan; Qingguo Xie; Zhi-Gang She; Zhihua Wang; Zan Huang; Hongliang Li
Journal:  Nat Med       Date:  2017-02-20       Impact factor: 53.440

Review 4.  From NAFLD to NASH to cirrhosis-new insights into disease mechanisms.

Authors:  Alexander Wree; Lori Broderick; Ali Canbay; Hal M Hoffman; Ariel E Feldstein
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-08-20       Impact factor: 46.802

5.  Tmbim1 is a multivesicular body regulator that protects against non-alcoholic fatty liver disease in mice and monkeys by targeting the lysosomal degradation of Tlr4.

Authors:  Guang-Nian Zhao; Peng Zhang; Jun Gong; Xiao-Jing Zhang; Pi-Xiao Wang; Miao Yin; Zhou Jiang; Li-Jun Shen; Yan-Xiao Ji; Jingjing Tong; Yutao Wang; Qiao-Fang Wei; Yong Wang; Xue-Yong Zhu; Xin Zhang; Jing Fang; Qingguo Xie; Zhi-Gang She; Zhihua Wang; Zan Huang; Hongliang Li
Journal:  Nat Med       Date:  2017-05-08       Impact factor: 53.440

6.  Toll-like receptor-4 mediates obesity-induced non-alcoholic steatohepatitis through activation of X-box binding protein-1 in mice.

Authors:  Dewei Ye; Francois Y L Li; Karen S L Lam; Huating Li; Weiping Jia; Yu Wang; Kwan Man; Chung Mau Lo; Xiaokun Li; Aimin Xu
Journal:  Gut       Date:  2012-01-17       Impact factor: 23.059

7.  Toll-like receptor 4 signaling in liver injury and hepatic fibrogenesis.

Authors:  Jinsheng Guo; Scott L Friedman
Journal:  Fibrogenesis Tissue Repair       Date:  2010-10-21

Review 8.  TMBIM protein family: ancestral regulators of cell death.

Authors:  D Rojas-Rivera; C Hetz
Journal:  Oncogene       Date:  2014-02-24       Impact factor: 8.756

  8 in total
  3 in total

1.  Genetic inactivation of the LIGHT (TNFSF14) cytokine in mice restores glucose homeostasis and diminishes hepatic steatosis.

Authors:  Andrea Herrero-Cervera; Ángela Vinué; Deborah J Burks; Herminia González-Navarro
Journal:  Diabetologia       Date:  2019-08-06       Impact factor: 10.122

2.  Agaricus brasiliensis KA21 May Prevent Diet-Induced Nash Through Its Antioxidant, Anti-Inflammatory, and Anti-Fibrotic Activities in the Liver.

Authors:  Anna Nakamura; Qi Zhu; Yoko Yokoyama; Naho Kitamura; Sena Uchida; Kayo Kumadaki; Kazuo Tsubota; Mitsuhiro Watanabe
Journal:  Foods       Date:  2019-11-04

3.  Integrated strategy of RNA-sequencing and network pharmacology for exploring the protective mechanism of Shen-Shi-Jiang-Zhuo formula in rat with non-alcoholic fatty liver disease.

Authors:  Zheng Xu; Fan-Wei Wu; Xuan Niu; Xiao-Peng Lu; Yan-Rong Li; Shu-Ting Zhang; Jun-Zhao Ou; Xue-Mei Wang
Journal:  Pharm Biol       Date:  2022-12       Impact factor: 3.889

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.